Orion Group (ORN) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Full year 2024 revenue grew 11.9% to $796.4 million, with gross profit up 48% to $91 million and adjusted EBITDA up 76% to $41.9 million.
Q4 2024 contract revenues rose 7.6% to $217 million, with GAAP net income of $6.8 million and adjusted net income of $6.4 million.
Backlog at year-end was $729 million, with total backlog plus early 2025 awards reaching $977 million and a pipeline expanding to $16 billion.
Strategic focus on business development, operational efficiency, and strong partnerships led to repeat business and new project wins.
Management expects 2026 to be a year of transformational growth, driven by improved execution and margin expansion.
Financial highlights
Q4 2024 gross profit margin rose to 14% from 11.4% year-over-year, with adjusted EBITDA of $17.1 million (7.9% margin).
Full-year adjusted EBITDA margin was 5.3%, and adjusted EPS was $0.15.
Cash flow from operations was $12.7 million for 2024; ended Q4 with $28.3 million in cash and $23.2 million in debt.
Q4 2024 included a $6.9 million intangible asset impairment loss and a $5.2 million gain from property sale.
$26.4 million was raised from common stock issuance in 2024.
Outlook and guidance
2025 revenue expected between $800 million and $850 million; adjusted EBITDA guidance is $42 million–$46 million.
Adjusted EPS for 2025 projected at $0.11–$0.17.
CapEx for 2025 forecasted at $25 million–$35 million, with most funded from operating cash flow.
Focus remains on backlog growth in 2025 to drive significant revenue in 2026.
Management expects margin expansion and continued backlog strength in 2025.
Latest events from Orion Group
- Revenue up 5.3% in Q2; net loss widened, but backlog and pipeline support strong 2025 outlook.ORN
Q2 20249 Jul 2026 - 2025 saw strong revenue and margin growth, with 2026 guidance boosted by a $23B pipeline.ORN
Q4 20258 Jul 2026 - New China licensing deal and Honey Birdette growth drive revenue and balance sheet improvement.ORN
38th Annual Roth Conference24 Jun 2026 - All proposals passed with strong support; retiring directors were honored and no questions raised.ORN
AGM 202619 May 2026 - Q1 2026 revenue rose 15% to $216.3M, net income hit $4.7M, and backlog reached $668M.ORN
Q1 202630 Apr 2026 - 2026 guidance forecasts strong revenue and EBITDA growth, fueled by a $24B opportunity pipeline.ORN
Investor presentation29 Apr 2026 - Shareholders to vote on director elections, executive pay, auditor ratification, and key amendments.ORN
Proxy filing1 Apr 2026 - Shareholders will vote on director elections, compensation, auditor, and key governance amendments.ORN
Proxy filing1 Apr 2026 - Proxy covers director elections, pay, auditor, governance, and incentive plan amendments.ORN
Proxy Filing17 Mar 2026